Aptamers News and Research

RSS
Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Protein-based CHD risk score developed

Protein-based CHD risk score developed

Scientists provide overview of most promising compounds to combat prostate cancer

Scientists provide overview of most promising compounds to combat prostate cancer

University of Oxford, SomaLogic partner to discover protein biomarkers for clinical diseases and conditions

University of Oxford, SomaLogic partner to discover protein biomarkers for clinical diseases and conditions

New sensor can detect estrogen levels in liquids

New sensor can detect estrogen levels in liquids

Replacing animal-derived antibodies with modern technologies can improve quality of research, reduce costs

Replacing animal-derived antibodies with modern technologies can improve quality of research, reduce costs

UC researcher awarded NCI grant to study effect of MED1 protein on HER2-positive breast cancer

UC researcher awarded NCI grant to study effect of MED1 protein on HER2-positive breast cancer

Magnetizing biomolecules: an interview with Dr. Fred Whipple, AMSBIO

Magnetizing biomolecules: an interview with Dr. Fred Whipple, AMSBIO

New light-triggered strategy can provide accurate control over aptamer-based therapeutics

New light-triggered strategy can provide accurate control over aptamer-based therapeutics

AMSBIO introduces revolutionary magnetic technology for bioseparations

AMSBIO introduces revolutionary magnetic technology for bioseparations

Celsion signs definitive asset purchase agreement to acquire EGEN

Celsion signs definitive asset purchase agreement to acquire EGEN

Researchers find new technique to detect just a handful of lurking tumor cells

Researchers find new technique to detect just a handful of lurking tumor cells

Aptamer kits for cell isolation and flow cytometry introduced by AMSBIO

Aptamer kits for cell isolation and flow cytometry introduced by AMSBIO

NOXXON Pharma reports interim data from two phase IIa studies of anti-CXCL12/SDF-1 Spiegelmer NOX-A12

NOXXON Pharma reports interim data from two phase IIa studies of anti-CXCL12/SDF-1 Spiegelmer NOX-A12

Chemists develop new method for parallel protein analysis

Chemists develop new method for parallel protein analysis

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

Researchers develop RNA aptamers that inhibit HCV replication

Researchers develop RNA aptamers that inhibit HCV replication

New range of Aptamer Protein Precipitation Kits announced by AMSBIO

New range of Aptamer Protein Precipitation Kits announced by AMSBIO

Experimental drug can reduce breast-cancer aggressiveness, restore drug-sensitivity

Experimental drug can reduce breast-cancer aggressiveness, restore drug-sensitivity

New apatamer can boost therapeutic effect of cell-based vaccines

New apatamer can boost therapeutic effect of cell-based vaccines